State of Tennessee, Department of Treasury’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-11,367
| Closed | -$127K | – | 1673 |
|
|
2023
Q3 | $127K | Sell |
11,367
-755
| -6% | -$12.2K | ﹤0.01% | 1545 |
|
|
2023
Q2 | $259K | Buy |
12,122
+604
| +5% | +$17.8K | ﹤0.01% | 1550 |
|
|
2023
Q1 | $466K | Sell |
11,518
-1,624
| -12% | -$77.5K | ﹤0.01% | 1375 |
|
|
2022
Q4 | $611K | Buy |
13,142
+386
| +3% | +$17.6K | ﹤0.01% | 1288 |
|
|
2022
Q3 | $662K | Buy |
12,756
+762
| +6% | +$44.5K | ﹤0.01% | 1232 |
|
|
2022
Q2 | $567K | Sell |
11,994
-28
| -0.2% | -$1.52K | ﹤0.01% | 1297 |
|
|
2022
Q1 | $856K | Buy |
12,022
+1,794
| +18% | +$117K | ﹤0.01% | 1232 |
|
|
2021
Q4 | $764K | Sell |
10,228
-319
| -3% | -$25K | ﹤0.01% | 1233 |
|
|
2021
Q3 | $600K | Sell |
10,547
-36
| -0.3% | -$1.78K | ﹤0.01% | 1310 |
|
|
2021
Q2 | $466K | Sell |
10,583
-200
| -2% | -$9.79K | ﹤0.01% | 1393 |
|
|
2021
Q1 | $532K | Buy |
10,783
+523
| +5% | +$26.1K | ﹤0.01% | 1309 |
|
|
2020
Q4 | $432K | Buy |
10,260
+773
| +8% | +$34K | ﹤0.01% | 1307 |
|
|
2020
Q3 | $434K | Hold |
9,487
| – | – | ﹤0.01% | 1212 |
|
|
2020
Q2 | $476K | Sell |
9,487
-745
| -7% | -$38.6K | ﹤0.01% | 1180 |
|
|
2020
Q1 | $526K | Sell |
10,232
-170
| -2% | -$9.06K | ﹤0.01% | 1088 |
|
|
2019
Q4 | $643K | Sell |
10,402
-1,387
| -12% | -$86K | ﹤0.01% | 1187 |
|
|
2019
Q3 | $708K | Buy |
11,789
+1,009
| +9% | +$75K | ﹤0.01% | 1163 |
|
|
2019
Q2 | $909K | Sell |
10,780
-51
| -0.5% | -$4.59K | ﹤0.01% | 1048 |
|
|
2019
Q1 | $1.03M | Buy |
10,831
+397
| +4% | +$35.6K | 0.01% | 1018 |
|
|
2018
Q4 | $739K | Buy |
10,434
+650
| +7% | +$49.8K | ﹤0.01% | 1092 |
|
|
2018
Q3 | $837K | Sell |
9,784
-93
| -0.9% | -$9.32K | ﹤0.01% | 1133 |
|
|
2018
Q2 | $1.15M | Sell |
9,877
-345
| -3% | -$34.4K | 0.01% | 1021 |
|
|
2018
Q1 | $827K | Sell |
10,222
-1,074
| -10% | -$82.7K | ﹤0.01% | 1133 |
|
|
2017
Q4 | $663K | Sell |
11,296
-276
| -2% | -$13.8K | ﹤0.01% | 1270 |
|
|
2017
Q3 | $542K | Sell |
11,572
-731
| -6% | -$29.4K | ﹤0.01% | 1310 |
|
|
2017
Q2 | $443K | Hold |
12,303
| – | – | ﹤0.01% | 1381 |
|
|
2017
Q1 | $379K | Buy |
12,303
+1,857
| +18% | +$57.8K | ﹤0.01% | 1416 |
|
|
2016
Q4 | $350K | Hold |
10,446
| – | – | ﹤0.01% | 1430 |
|
|
2016
Q3 | $278K | Hold |
10,446
| – | – | ﹤0.01% | 1376 |
|
|
2016
Q2 | $230K | Hold |
10,446
| – | – | ﹤0.01% | 1376 |
|
|
2016
Q1 | $307K | Buy |
10,446
+246
| +2% | +$6.85K | ﹤0.01% | 1304 |
|
|
2015
Q4 | $337K | Buy |
+10,200
| New | +$332K | ﹤0.01% | 1298 |
|
Other funds holding ENTA
AC
FCM
KAM
State of Tennessee, Department of Treasury's ENTA Position: Q4 2023 in Review
State of Tennessee, Department of Treasury sold out of Enanta Pharmaceuticals (ENTA) in Q4 2023, closing a stake of 11,367 shares — an estimated $127K sold.
State of Tennessee, Department of Treasury first reported a position in ENTA in Q4 2015 and held it in 32 quarters. The position peaked at $1.15M in Q2 2018. 106 funds tracked by Wall St. Rank hold ENTA as of Q4 2023.
- State of Tennessee, Department of Treasury reported no remaining Enanta Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
- State of Tennessee, Department of Treasury sold 11,367 Enanta Pharmaceuticals shares in Q4 2023, an estimated $127K.
- State of Tennessee, Department of Treasury first reported a position in Enanta Pharmaceuticals in Q4 2015 and held it in 32 quarters.
- State of Tennessee, Department of Treasury's Enanta Pharmaceuticals position peaked at $1.15M in Q2 2018.
- 106 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q4 2023.
Based on State of Tennessee, Department of Treasury's 13F filing for Q4 2023, filed 14 Feb 2024.